open access

Vol 5, No 5 (2016)
Review
Published online: 2017-02-03
Get Citation

Intestinal microbiota and its relationship with diabetes and obesity

Patrycja Pokrzywnicka, Janusz Gumprecht
DOI: 10.5603/DK.2016.0029
·
Clinical Diabetology 2016;5(5):164-172.

open access

Vol 5, No 5 (2016)
Review
Published online: 2017-02-03

Abstract

The number of people who are obese and who suffer from type 2 diabetes is one of the most prominent health problems of our time. Among commonly known reasons we may distinguish excess of food in relation to how much food energy our organism really needs (change in life style and diet), genetic predisposition, endocrine disorders, and use of medicines. However, according to latest reports, intestinal flora plays a significant part in aetiology of these medical conditions. The fact that intestinal microflora may affect body weight, sensitivity to insulin, metabolism of sugars and lipids leads to a conclusion that any change within intestinal microflora may be the reason for pathogenesis of obesity and diabetes. Moreover, any attempt to modify it may cause decrease or limitation of the intensity of the medical conditions mentioned above. Intestinal microbiota is now one of the most developing subjects for research. Many of the world’s medical projects including MetaHIT (UE and China), MicrOBES (France), Human Microbiome Project — HMP (USA) focus on research on the role of intestinal bacteria for people’s health. Scientists are particularity interested in the possibility of modification of the intestinal microorganisms in order to treat or prevent many conditions including obesity and other diseases of affluence.

Abstract

The number of people who are obese and who suffer from type 2 diabetes is one of the most prominent health problems of our time. Among commonly known reasons we may distinguish excess of food in relation to how much food energy our organism really needs (change in life style and diet), genetic predisposition, endocrine disorders, and use of medicines. However, according to latest reports, intestinal flora plays a significant part in aetiology of these medical conditions. The fact that intestinal microflora may affect body weight, sensitivity to insulin, metabolism of sugars and lipids leads to a conclusion that any change within intestinal microflora may be the reason for pathogenesis of obesity and diabetes. Moreover, any attempt to modify it may cause decrease or limitation of the intensity of the medical conditions mentioned above. Intestinal microbiota is now one of the most developing subjects for research. Many of the world’s medical projects including MetaHIT (UE and China), MicrOBES (France), Human Microbiome Project — HMP (USA) focus on research on the role of intestinal bacteria for people’s health. Scientists are particularity interested in the possibility of modification of the intestinal microorganisms in order to treat or prevent many conditions including obesity and other diseases of affluence.

Get Citation

Keywords

obesity, intestinal microbiota, diabetes mellitus, short chain fatty acids, prebiotics, probiotics

About this article
Title

Intestinal microbiota and its relationship with diabetes and obesity

Journal

Clinical Diabetology

Issue

Vol 5, No 5 (2016)

Pages

164-172

Published online

2017-02-03

DOI

10.5603/DK.2016.0029

Bibliographic record

Clinical Diabetology 2016;5(5):164-172.

Keywords

obesity
intestinal microbiota
diabetes mellitus
short chain fatty acids
prebiotics
probiotics

Authors

Patrycja Pokrzywnicka
Janusz Gumprecht

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl